ID   ACI-158
AC   CVCL_D716
SY   ACI_158
DR   cancercelllines; CVCL_D716
DR   Cosmic; 1622905
DR   GEO; GSM3161708
DR   GEO; GSM3161709
DR   Wikidata; Q54608381
RX   PubMed=21882256;
CC   Sequence variation: Mutation; HGNC; HGNC:9302; PPP2R1A; Simple; p.Pro179Arg (c.536C>G); ClinVar=VCV000376504; Zygosity=Unspecified (PubMed=21882256).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=21882256).
CC   Omics: Chromatin accessibility by ATAC-seq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
RX   PubMed=21882256; DOI=10.1002/mc.20850;
RA   Nagendra D.C., Burke J. 3rd, Maxwell G.L., Risinger J.I.;
RT   "PPP2R1A mutations are common in the serous type of endometrial
RT   cancer.";
RL   Mol. Carcinog. 51:826-831(2012).
//